A Brief History of Aurora Cannabis Inc. (ACB)

Foundation and Initial Growth

Aurora Cannabis Inc. was founded in 2006 by Terry Booth, Steve Dobler, and Miguel Martin. The company was established in Alberta, Canada, originally operating under the name "Aurora Mountain." In October 2010, Aurora received its license to produce medical cannabis, becoming one of the first licensed producers in Canada.

By 2014, Aurora completed its initial public offering (IPO) on the Toronto Stock Exchange (TSE) under the symbol ACB, raising approximately $6 million in capital.

Expansion and Acquisitions

In the years following its IPO, Aurora aggressively pursued a strategy of expansion through acquisitions. In 2016, it acquired CanniMed Therapeutics, a significant move that expanded its market presence and production capabilities.

In 2017, Aurora acquired another major player, MedReleaf, for $3.2 billion, which was a key transaction in solidifying its position in the Canadian market.

Financial Performance and Market Position

As of the end of 2022, Aurora Cannabis reported revenues of $60.2 million for the third quarter, showcasing a decline of approximately 17% year-over-year. The company's net loss for the same period was $33 million.

Market Challenges and Strategic Adjustments

In 2021, Aurora Cannabis began implementing a restructuring plan aimed at reducing operational costs and focusing on high-margin products. This plan involved closing several cultivation facilities and shifting towards a more streamlined business model.

As of October 2023, Aurora Cannabis has pivoted towards international markets, particularly focusing on Europe, where it has established partnerships for medical cannabis distribution.

Current Initiatives and Future Outlook

The company is now focusing on developing products outside the recreational cannabis space, such as cannabidiol (CBD) and other health products. As of Q1 2023, Aurora’s total assets were reported at $1.4 billion and total liabilities at $500 million.

In 2023, Aurora Cannabis announced plans to invest $15 million in research and development for new product lines targeting the wellness sector.

A Who Owns Aurora Cannabis Inc. (ACB)

Major Shareholders

As of the latest available data in 2023, the ownership distribution of Aurora Cannabis Inc. (ACB) is as follows:

Top Institutional Shareholders

The following table lists the top institutional shareholders of Aurora Cannabis Inc. as of 2023:

Insider Ownership Breakdown

Insider ownership is primarily held by executives and board members. The specific breakdown is as follows:

Share Performance and Market Capitalization

As of October 2023, Aurora Cannabis Inc. (ACB) has the following financial metrics:

• Market Capitalization: $1.1 billion
• Current Share Price: $2.64
• 52-Week High: $4.16
• 52-Week Low: $1.50

Recent Ownership Changes

In 2023, there have been notable changes in ownership:

• Institutional ownership increased by 5% since early 2023.
• Insider ownership remained relatively stable, with a slight increase of 0.3%.
• Retail ownership reflects a growing interest among individual investors.

Conclusion of Ownership Overview

The ownership structure of Aurora Cannabis Inc. illustrates a diverse mix of institutional, insider, and retail investors. The significant retail presence suggests an engaged investor base. The ongoing developments in the cannabis market may influence future ownership dynamics.

Aurora Cannabis Inc. (ACB) Mission Statement

Company Overview

Aurora Cannabis Inc. is a Canadian company specializing in the production and distribution of medical and recreational cannabis products. Founded in 2006, it has established itself as a significant player in the global cannabis market.

Mission Statement

Aurora's mission statement reflects its commitment to providing high-quality cannabis products and advancing cannabis research. The mission emphasizes innovation, customer education, and the promotion of responsible use.

Core Values

• Quality: Commitment to producing premium cannabis products.
• Integrity: Adherence to ethical business practices.
• Innovation: Continuous investment in research and development.
• Community: Focus on social responsibility and community engagement.

Market Position

As of October 2023, Aurora Cannabis holds a market capitalization of approximately $1.2 billion. The company operates in 25 countries worldwide and has established a significant presence in both the medical and recreational cannabis markets.

Financial Performance

For the fiscal year ended June 30, 2023, Aurora Cannabis reported the following financial results:

Product Portfolio

Aurora Cannabis offers a diverse range of products catering to various consumer needs, including:

• Medical cannabis oils
• Recreational cannabis flower
• Edibles and beverages
• Topicals and capsules

Research and Development

The company invests heavily in R&D, with a budget of CAD 15 million allocated for the current fiscal year. This investment supports the development of new products and technologies aimed at enhancing the efficacy and safety of cannabis consumption.

Global Expansion

Aurora Cannabis has operations in several international markets, including:

• Germany
• Australia
• Italy
• United Kingdom

The company aims to expand its global footprint by entering additional markets in Europe and Latin America.

Community Engagement

Aurora Cannabis is committed to social responsibility, with initiatives including:

• Supporting local charities
• Promoting responsible cannabis use
• Engaging in educational outreach programs

Conclusion

Aurora Cannabis Inc. is dedicated to its mission of delivering high-quality cannabis products while maintaining a focus on innovation, integrity, and community engagement. Its financial performance and global strategy reflect its commitment to becoming a leader in the cannabis industry.

How Aurora Cannabis Inc. (ACB) Works

Business Model

Aurora Cannabis Inc. operates primarily in the cannabis industry, focusing on the cultivation, production, and distribution of cannabis products. The company is involved in both the medical and recreational cannabis markets, offering various products, including dried flower, oils, and softgel capsules.

Financial Performance

For the fiscal year ending June 30, 2023, Aurora Cannabis reported:

• Revenue: $47.0 million CAD
• Net Loss: $52.0 million CAD
• Gross Profit: $17.5 million CAD
• Cash and Cash Equivalents: $55.3 million CAD

Market Segmentation

Aurora Cannabis has diversified its product offerings to cater to different market segments:

Production Capacity

The company has a significant production capacity, with cultivation facilities across Canada. As of 2023, its annual production capacity is:

• Annual Cultivation Capacity: 150,000 kg
• Facility Area: 1.6 million square feet
• Number of Facilities: 12

Regulatory Environment

Aurora operates under strict regulations set by Health Canada, which include:

• Licensing Requirements: Must obtain licenses for cultivation and sales
• Quality Assurance: Compliance with Good Manufacturing Practices (GMP)
• Reporting Obligations: Regular financial and operational reporting required

Research and Development

The company invests significantly in R&D for product innovation, focusing on:

• New Strains Development
• Medical Applications of Cannabis
• Product Delivery Methods

As of 2023, Aurora Cannabis allocated approximately $5 million CAD for R&D activities.

Strategic Partnerships

Aurora has formed various strategic partnerships to enhance its market position:

• Partnership with the University of Alberta for cannabis research
• Collaboration with other cannabis producers for joint product development
• Distribution agreements with retailers across Canada

Stock Performance

As of October 2023, the stock performance of Aurora Cannabis (ACB) has shown:

• Market Capitalization: $1.5 billion CAD
• Current Share Price: $1.80 CAD
• 52-week Range: $1.00 - $3.50 CAD

Future Outlook

The company has outlined a strategy for future growth, including:

• Expansion into international markets
• Product diversification into edibles and beverages
• Increased focus on sustainability and eco-friendly practices

How Aurora Cannabis Inc. (ACB) Makes Money

Revenue Streams

Aurora Cannabis generates revenue primarily through the sale of cannabis products and services in various markets. In their fiscal year 2023, the company reported revenue of $85 million, reflecting a significant focus on both the medical and recreational cannabis markets.

Medical Cannabis Sales

Aurora's medical cannabis segment is a substantial contributor to its overall revenue. For the fiscal year 2023, the company reported medical cannabis sales totaling $50 million. This segment serves patients with various ailments, providing products that include oils, capsules, and dried flower.

Recreational Cannabis Sales

The recreational cannabis market has seen significant growth. In fiscal year 2023, Aurora's recreational sales reached $30 million, driven by increased consumer demand and the expansion of retail outlets across Canada.

International Markets

Aurora is expanding its footprint in international markets. The company reported $5 million in revenue from international markets, including Europe and Latin America, in the same fiscal year. This growth is supported by strategic partnerships and joint ventures.

Cost of Goods Sold (COGS)

The company incurs various costs associated with its revenue-generating activities. In fiscal year 2023, the COGS was reported at $50 million, which includes cultivation, processing, and distribution expenses.

Gross Profit

Aurora Cannabis achieved a gross profit of $35 million for fiscal year 2023, indicating a gross margin percentage of approximately 41%.

Operating Expenses

The operating expenses for Aurora Cannabis in fiscal year 2023 were noted at $60 million, representing costs related to research and development, sales and marketing, and administrative expenses.

Net Income

Aurora Cannabis reported a net loss of ($25 million) for fiscal year 2023, as it continues to invest heavily in growth and infrastructure.

Table of Financial Overview

Product Diversification

Aurora Cannabis is actively diversifying its product offerings to enhance revenue. Products include:

• Pre-rolls
• Edibles
• Concentrates
• Vaping products

Partnerships and Collaborations

The company engages in various strategic partnerships to drive revenue growth. Highlighted collaborations include:

• Distribution agreements with licensed retailers
• Joint ventures in research and product development

Future Growth Initiatives

Aurora Cannabis has outlined several initiatives to drive future revenue, including:

• Expansion into new markets
• Innovation in product lines
• Increased investment in marketing strategies

Market Trends and Challenges

Market trends impacting the financial landscape include:

• Increased legalization of cannabis
• Growing consumer acceptance
• Market saturation concerns